Kommentar
Spillover Effects in Clinical Trials
JAMA · 14.07.2026 · 336 (2) · 113
DOI: 10.1001/jama.2026.7858 ↗Kurz gefasst
Kommentar in der Zeitschrift JAMA, erschienen am 14.07.2026. Verfasst von Issa J Dahabreh und 1 weiteren Autor:innen. Beteiligte Einrichtung: CAUSALab, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- CAUSALab, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
- Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
- Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
- Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
- Statistical Editor, JAMA , Chicago, Illinois.
- David Geffen School of Medicine at UCLA, Los Angeles, California.
Zitieren
APA
Dahabreh, I. J., & Lewis, R. J. (2026). Spillover Effects in Clinical Trials. JAMA, 336(2), 113. https://doi.org/10.1001/jama.2026.7858
Vancouver
Dahabreh IJ, Lewis RJ. Spillover Effects in Clinical Trials. JAMA. 2026;336(2):113. doi:10.1001/jama.2026.7858
BibTeX
@article{Dahabreh2026,
author = {Dahabreh, Issa J and Lewis, Roger J},
title = {Spillover Effects in Clinical Trials},
journal = {JAMA},
year = {2026},
volume = {336},
number = {2},
pages = {113},
doi = {10.1001/jama.2026.7858}
}
EUVIMED